We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
KYMR icon
126
Kymera Therapeutics
KYMR
$8.59B
$8.59B $104.39 4.07%
TEM
127
Tempus AI
TEM
$8.49B
$8.49B $47.05 2.17%
RGEN icon
128
Repligen
RGEN
$8.45B
$8.45B $149.78 1.85%
ALKS icon
129
Alkermes
ALKS
$8.33B
$8.33B $49.67 0.28%
IMVT icon
130
Immunovant
IMVT
$8.08B
$8.08B $39.36 2.21%
PCVX icon
131
Vaxcyte
PCVX
$7.9B
$7.9B $54.69 2.17%
LQDA icon
132
Liquidia Corp
LQDA
$7.86B
$7.86B $88.38 5.4%
BRKR icon
133
Bruker
BRKR
$7.66B
$7.66B $50.30 21.8%
TGTX icon
134
TG Therapeutics
TGTX
$7.46B
$7.46B $48.73 5.54%
HIMS icon
135
Hims & Hers Health
HIMS
$7.44B
$7.44B $32.16 4.35%
COGT icon
136
Cogent Biosciences
COGT
$7.32B
$7.32B $42.84 10.2%
IBRX icon
137
ImmunityBio
IBRX
$7.28B
$7.28B $6.95 2.8%
RYTM icon
138
Rhythm Pharmaceuticals
RYTM
$7.26B
$7.26B $105.78 2.92%
PACS icon
139
PACS Group
PACS
$7.09B
$7.09B $44.81 0.7%
CHE icon
140
Chemed
CHE
$7.05B
$7.05B $539.72 0.16%
LNTH icon
141
Lantheus
LNTH
$6.58B
$6.58B $101.11 0.08%
BLLN
142
BillionToOne Inc
BLLN
$6.54B
$6.54B $142.25 3.59%
ERAS icon
143
Erasca
ERAS
$6.38B
$6.38B $18.38 3.03%
MIRM icon
144
Mirum Pharmaceuticals
MIRM
$6.36B
$6.36B $104.33 0.25%
BLTE
145
Belite Bio
BLTE
$6.3B
$6.3B $157.27 1.6%
CGON icon
146
CG Oncology
CGON
$6.3B
$6.3B $71.40 3.25%
TFX icon
147
Teleflex
TFX
$6.2B
$6.2B $140.12 0.3%
TWST icon
148
Twist Bioscience
TWST
$6.19B
$6.19B $99.44 1.6%
XENE icon
149
Xenon Pharmaceuticals
XENE
$6.19B
$6.19B $64.01 2.81%
HNGE
150
Hinge Health
HNGE
$6.15B
$6.15B $79.42 2.28%

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.94T.

The largest by market cap are Eli Lilly (LLY) at $995B, Johnson & Johnson (JNJ) at $614B and AbbVie (ABBV) at $431B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.94T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $995B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.